Surgical Oncology
Chief Division of Surgical Oncology West Michigan Cancer Center, Associate Professor of Surgery Western Michigan University Homer Stryker M.D. School of Medicine, USA
Gitonga Munene, MD, is board certified in general surgeon with West Michigan Cancer Center in Kalamazoo, Michigan, as well as holding an associate professorship in the Department of Surgery at Western Michigan University Homer Stryker M.D. School of Medicine. He earned his medical degree from the Northwestern University Feinberg School of Medicine in Chicago and completed a surgical residency at Georgetown University Hospital in Washington, DC. He received fellowship training in surgical oncology from Tom Baker Cancer Center in Calgary, Alberta, Canada and from Massachusetts General Hospital in Boston. Dr. Munene’s clinical interests include surgery for gastrointestinal cancers—gastric, hepatobiliary, pancreatic, and metastatic colon—as well as thyroid cancer, melanoma and soft tissue sarcomas. He is also trained to provide treatment for peritoneal-based malignancies using hyperthermic intraperitoneal chemotherapy (HIPEC) – which is new to the Southwest Michigan region.
Selected publications from PubMed
Financial Toxicity in Complex Gastrointestinal Surgery and Correlation With Patient-reported Outcomes.
Young L, Vergara R, Henriquez J, Fong A, Al-Assil T, Shebrain S, Munene G
Ann Surg. 2026 May 1;283(5):776-782 doi: 10.1097/SLA.0000000000006559.
Shared Decision-Making in Pancreatic Surgery.
Trobaugh J, Fuqua W, Folkert K, Khalil S, Shebrain S, Munene G
Ann Surg Open. 2022 Sep;3(3):e196 doi: 10.1097/AS9.0000000000000196.
Trends of the Extra-Hepatic Biliary Cancer and Its Surgical Management: A Cross-Sectional Study From the National Cancer Database.
Tuma F, Abbaszadeh-Kasbi A, Munene G, Shebrain S, Durchholz WC
Cureus. 2022 Aug;14(8):e27584 doi: 10.7759/cureus.27584.
Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels Compared with Recommended Thromboprophylaxis and Rates of Clinically Evident Venous Thromboembolism in Surgical Oncology Patients.
Kramme K, Sarraf P, Munene G
J Am Coll Surg. 2020 Mar;230(3):314-321 doi: 10.1016/j.jamcollsurg.2019.11.012.
Understanding Disparities in Breast Cancer Care in Memphis, Tennessee.
Lamb EP, Pritchard FE, Nouer SS, Tolley EA, Boyd BS, Davidson JT, Munene G, Fleming MD
Am Surg. 2018 May 1;84(5):620-627.
The topic of this talk is human hemostatic agents in surgery and their availability in the marketplace. The market offers a significant number of choices available for hemostatic agents, however, there’s a lack of standardization that has led to suboptimal use of hemostasis. Some studies point out that surgeons choose hemostats predominantly by site and situation. When it comes to site definition, the focus is on anatomy & critical surrounding anatomic structures that could be impacted. Nevertheless, the situation encompasses intra-operative versus post-operative bleeding risk, type of access, type of tissue surface, and bleeding intensity. It is very important to recognize the five bleeding situations that emerged. Doctor Munene discusses the solutions in the marketplace to deal with this specific kind of complications. Finally, a graph is discussed where the different kinds of bleeding can be identified and tips are given to correctly use all solutions.
With Johnson & Johnson MedTech
Published
Jul 2022
Surgical bleeding can adversely affect patient outcome, hospital costs, and resources. Intraoperative bleeding is a major cause of cases being opened from MIS procedure with challenging and uncontrollable bleeding during surgery associated with high morbidity and mortality rates. As surgeons we must be OR READY!
With Johnson & Johnson MedTech
Published
May 2022
Help your network discover Dr. Gitonga Munene's clinical expertise.
